Genelabs completes link-up with Chiron and Ortho
This article was originally published in Clinica
US companies Genelabs, Chiron and Ortho last week signed definitive agreements on a worldwide diagnostics alliance. The alliance, proposed in March this year (see Clinica No 646, p 1), will centre on hepatitis and retrovirus technologies as well as new in vitro diagnostic products.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.